General Information of Drug (ID: DMWPSJR)

Drug Name
TAK-831 Drug Info
Indication
Disease Entry ICD 11 Status REF
Friedreich's ataxia 8A03.10 Phase 2 [1]
Schizophrenia 6A20 Phase 1 [2]
Cross-matching ID
PubChem CID
71270546
TTD Drug ID
DMWPSJR

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug(s) Targeting D-amino acid oxidase (DAO)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SEP-227900 DMXRU72 Cognitive impairment 6D71 Terminated [3]
SEP-227900 DMXRU72 Cognitive impairment 6D71 Terminated [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
D-amino acid oxidase (DAO) TT7Y3EJ OXDA_HUMAN Inhibitor [2]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors. Open Med Chem J. 2010; 4: 3-9.